The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Hookipa Pharma
A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16+ cancers.
 
Bharat Burman
Employment - Janssen (I)
Stock and Other Ownership Interests - Janssen (I)
 
Jiaxin Niu
No Relationships to Disclose
 
Rom S. Leidner
Consulting or Advisory Role - Merck; Oncolys BioPharma; Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Ding Wang
Consulting or Advisory Role - Qurgen; Qurgen
Travel, Accommodations, Expenses - Qurgen
 
Debra L. Richardson
Consulting or Advisory Role - AstraZeneca; Bayer; Foundation Medicine; Genentech/Roche; Ipsen; Mersana; Tesaro
Research Funding - Aravive (Inst); ArQule (Inst); AstraZeneca (Inst); Deciphera (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Harpoon therapeutics (Inst); Hookipa Biotech (Inst); Innovent Biologics (Inst); Karyopharm Therapeutics (Inst); Lycera (Inst); Merck (Inst); Mersana (Inst); Roche (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Agenus; Karyopharm Therapeutics; Merck; Roche; Tesaro
 
Corinne Iacobucci
Employment - Daiichi Sankyo; Hookipa Pharma
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Bayer; Daiichi Sankyo
 
Andy Hwang
Employment - Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
Research Funding - Hookipa Pharma
Travel, Accommodations, Expenses - Hookipa Pharma
 
Xiaoping Qing
No Relationships to Disclose
 
Igor Matushansky
Employment - Hookipa Pharma
Leadership - Crescendo Biologics; Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
 
Dmitriy Zamarin
Consulting or Advisory Role - ACM Biolabs; Agenus; Merck; Synlogic; Tesaro; Trieza Therapeutics; Western Oncolytics
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
 
Alan Loh Ho
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; CureVac; CureVac; Eisai; Genzyme; Merck; Novartis; Regeneron; Sanofi; Sun Pharma; TRM Oncology
Speakers' Bureau - Medscape; Novartis; Omniprex America
Research Funding - Allos Therapeutics; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Ayala Pharmaceuticals; Ayala Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Elevar Therapeutics; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly; Merck; Novartis; Novartis; Novartis; Pfizer
Travel, Accommodations, Expenses - Ayala Pharmaceuticals; Ignyta; Janssen Oncology; Klus Pharma; Kura Oncology; Kura Oncology; Kura Oncology; Merck
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte
Research Funding - AstraZeneca; Atara Biotherapeutics; Bayer (Inst); Boehringer Ingelheim; Eisai (Inst); Exelixis; Genentech/Roche (Inst); Lilly (Inst); MedImmune; Merck; Novartis; Regeneron
 
Marshall R. Posner
Stock and Other Ownership Interests - Promedior
Consulting or Advisory Role - Cel-Sci; Merck
Research Funding - advaxis (Inst); AstraZeneca (Inst); Formation Biologics (Inst); Hookipa Pharma; Innate Pharma (Inst); MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - anti-Pseudomonas antibody (Inst); anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor